| P. falciparumantibody exposurea | Proportion of individuals with P. falciparuminfectionb | P. falciparumantibody exposure and infection prevalencec | Fever prevalence in the two weeks prior to survey | Fever prevalence on the day of survey | Use of ITN |
---|---|---|---|---|---|---|
Totals | 9.9 (7.5 - 12.3) [517/4769] | 0.50 (0.28 - 0.73) [42/7151] | 10.5 (8.1 - 13.0) [550/4769] | 5.2 (4.11 - 6.3) [254/4769] | 1.9 (1.4 - 2.4) [91/4769] | 14.5 (11.2 - 17.7) [740/4769] |
< 5 years | 6.9 (3.7 - 10.2) [46/649] | 0.23 (0.01 - 0.45) [4/968] | 7.1 (3.9 - 10.4) [49/649] | 18.5 (12.3 - 24.7) [110/649] | 4.3 (2.3 - 6.4) [27/649] | 15.8 (10.0 - 21.6) [114/649] |
5 - 9 years | 4.9 (2.8 - 6.9) [37/703] | 0.61 (-0.03 - 1.24) [6/1015] | 5.7 (3.4 - 7.9) [43/703] | 6.6 (4.5 - 8.6) [46/703] | 3.8 (2.3 - 5.2) [26/703] | 17.1 (11.8 - 22.5) [126/703] |
10 - 14 years | 5.0 (2.2 - 7.9) [23/441] | 0.34 (-0.06 - 0.74) [3/644] | 5.6 (2.7 - 8.5) [26/441] | 1.9 (0.6 - 3.3) [9/441] | 0.8 (0.0 - 1.6) [5/441] | 12.6 (8.6 - 16.6) [55/441] |
15 - 34 years | 11.4 (8.4 - 14.3) [202/1626] | 0.49 (0.16 - 0.82) [14/2454] | 11.9 (8.9 - 14.9) [211/1626] | 2.5 (1.7 - 3.4) [48/1626] | 0.9 (0.4 - 1.4) [16/1626] | 12.5 (9.8 - 15.4) [236/1626] |
35 - 49 years | 14.0 (10.0 - 17.9) [132/833] | 0.64 (0.24 - 1.05) [9/1283] | 14.7 (10.8 - 18.8) [141/833] | 3.4 (1.8 - 5.0) [30/833] | 1.6 (0.7 - 2.6) [14/833] | 16.7 (12.3 - 21.0) [143/833] |
50 + years | 14.2 (9.7 - 18.7) [76/510] | 0.67 (0.11 - 1.23) [6/773] | 15.0 (10.4 - 19.5 [79/510] | 2.2 (0.8 - 3.6) [11/510] | 0.5 (-0.0 - 1.3) [2/510] | 13.6 (9.4 - 17.8) [66/510] |
χ2 for trend | 68.27, p= 0.0001 | 3.29, p= 0.5568 | 67.04, p= 0.0001 | 268.71, p= 0.0001 | 50.06, p= 0.0001 | 14.23, p= 0.0913 |